Cancer is a leading cause of global death, accounting for nearly 10 million deaths in 2020. However, over the past years, the treatment paradigm of Cancer has transformed with several therapies such as chemotherapies, radiation therapies and immunotherapies available to treat cancer. Even then, there exists a large segment of the Cancer patient pool who do not get benefitted from the available therapies owing to severe side effects, resistance to available therapies, non-eligibility for a particular therapy and so on.
Intratumoral immunotherapy is a potential therapeutic strategy that targets the tumor using it as a vaccine against itself. It is a promi...
